{"id":1965,"date":"2022-10-26T16:17:47","date_gmt":"2022-10-26T20:17:47","guid":{"rendered":"https:\/\/www.biosyent.com\/nouvelles\/"},"modified":"2026-02-12T14:48:34","modified_gmt":"2026-02-12T19:48:34","slug":"nouvelles","status":"publish","type":"page","link":"https:\/\/www.biosyent.com\/fr\/nouvelles\/","title":{"rendered":"Nouvelles"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb][vc_column]<div class=\"wpb-decorationline stretchy-left\"><div><\/div><div><\/div><\/div>[\/vc_column][\/vc_row][vc_row css=\u00a0\u00bb.vc_custom_1668801695899{margin-bottom: 30px !important;}\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n<h3>Nouvelles<\/h3>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb][vc_column]<div class=\"wpb_pressreleasesbyyear2\"><div class=\"container\"><div class=\"year_selector\"><h4>Press Releases &nbsp;<\/h4> <form style=\"display:inline-block vertical-align: text-bottom\" id=\"formFilter\" method=\"GET\"><select name=\"theyear\" id=\"theyear\" class=\"niceselect filterbyyear\"><option selected=\"selected\" value=\"0\">Filter by Year<\/option><option value=\"2026\">2026<\/option><option value=\"2025\">2025<\/option><option value=\"2024\">2024<\/option><option value=\"2023\">2023<\/option><option value=\"2022\">2022<\/option><option value=\"2021\">2021<\/option><option value=\"2020\">2020<\/option><option value=\"2019\">2019<\/option><option value=\"2018\">2018<\/option><option value=\"2017\">2017<\/option><option value=\"2016\">2016<\/option><option value=\"2015\">2015<\/option><option value=\"2014\">2014<\/option><\/select><\/form><\/div><\/div> <div class=\"year\"><div class=\"container\">2026<\/div><\/div>   <div class=\"container\">      <div class=\"tabs\"><div class=\"active quarter1\" data-quarter=\"quarter1\">Q1<\/div><\/div>      <div class=\"pages\"><div class=\"active quarter1\"  data-quarter=\"quarter1\">\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>avril 1, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/03\/Press-release-1-FeraMAX-2026-FINAL-EN.pdf\">FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>mars 24, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/03\/Press-Release-re_-RSU_Grants_Mar_24-2026.pdf\">BioSyent Announces Grant of Restricted Share Units<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>mars 19, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/03\/PR-2026-03-19-Q4-Earnings-Release-FINAL-v4-CLEAN.pdf\">BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>mars 12, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/03\/PR-2026-03-12-Q4-Pre-Release-PR-FINAL.pdf\">BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>mars 2, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/02\/SPA-Closing-PR-Mar-2-2026-FINAL.pdf\">BioSyent Announces Closing of the Acquisition of Oral Science Inc.<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>f\u00e9vrier 9, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/02\/SPA-Signing-PR-FINAL-Feb-9-2026-FR.pdf\">BioSyent annonce l'acquisition d'Oral Science Inc.<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"item\">\n\t\t\t\t\t\t\t\t<div>janvier 29, 2026<\/div>\n\t\t\t\t\t\t\t\t<div><a target=\"_blank\" href=\"https:\/\/www.biosyent.com\/wp-content\/uploads\/2026\/01\/PR-2026-01-29-Q1-2026-Dividend-Declaration-FINAL.pdf\">BioSyent Declares First Quarter 2026 Dividend<\/a><br><\/div>\n\t\t\t\t\t\t\t<\/div><\/div><\/div>   <\/div><\/div>[\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1668801090084{margin-top: 40px !important;margin-bottom: 10px !important;padding-top: 20px !important;padding-bottom: 40px !important;background-color: #f3f9eb !important;}\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n<h4>Entrevues<\/h4>\n<p class=\"s4\"><span class=\"s2\">\u00c9coutez notre PDG nous parler de BioSyent.<\/span><\/p>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=LW5akxf7U9k\u00a0\u00bb align=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=u-mY4jFzqYA\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=ej_ZbQXdRx0&Prime; css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=9AHlGi9e2RM\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=\u00a0\u00bb.vc_custom_1666897497377{margin-top: 40px !important;}\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n<h4>Couverture<\/h4>\n<p class=\"s4\"><span class=\"s2\">Vous pouvez<\/span> <span class=\"s2\">lire<\/span> <span class=\"s2\">les derni\u00e8res nouvelles sur BioSyent, notre portefeuille<\/span> <span class=\"s2\">et<\/span> <span class=\"s2\">nos<\/span> <span class=\"s2\">produits.<\/span><\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=\u00a0\u00bbcoverage-row\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1666897546265{margin-bottom: 60px !important;}\u00a0\u00bb][vc_column]\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2024\/02\/gelclair_carton.jpg)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Nov 20, 2023<\/div>\n                <div class=\"title\">BioSyent annonce la disponibilit\u00e9 de Gelclair\u00ae au Canada<\/div>\n                <div class=\"text\">BioSyent Inc. (``BioSyent``, ``la Soci\u00e9t\u00e9``, Bourse de croissance TSX : RX) a le plaisir d'annoncer que sa filiale, BioSyent Pharma Inc. a commenc\u00e9 les premi\u00e8res exp\u00e9ditions de son nouveau produit de soins de soutien en oncologie, Gelclair\u00ae, \u00e0 des grossistes au Canada.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/RX-X\/pressreleases\/22151579\/22151579\/\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2024\/03\/Screenshot-2024-03-11-094957.jpg)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Oct 18, 2023<\/div>\n                <div class=\"title\">BioSyent lance menopauseinformation.ca \u00e0 l'occasion de la Journ\u00e9e mondiale de la m\u00e9nopause<\/div>\n                <div class=\"text\">BioSyent Inc. (``BioSyent``, Bourse de croissance TSX : RX) a le plaisir d'annoncer le lancement de menopauseinformation.ca, une plateforme en ligne compl\u00e8te con\u00e7ue pour donner aux femmes p\u00e9rim\u00e9nopaus\u00e9es et m\u00e9nopaus\u00e9es du Canada les moyens d'agir.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/RX-X\/pressreleases\/21211495\/\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2024\/02\/feramax-pd-maintenance-45.webp)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Mar 07, 2023<\/div>\n                <div class=\"title\">BioSyent annonce le lancement du nouveau FeraMAX\u00ae Pd Maintenance 45<\/div>\n                <div class=\"text\">\u00c0 la veille de la Journ\u00e9e internationale de la femme, BioSyent Inc. (``BioSyent``, ``la Soci\u00e9t\u00e9``, Bourse de croissance TSX : RX) c\u00e9l\u00e8bre le lancement canadien de FeraMAX\u00ae Pd Maintenance 45 par sa filiale, BioSyent Pharma Inc. FeraMAX\u00ae Pd Maintenance 45 est le troisi\u00e8me produit de BioSyent incorporant le complexe polydextrose-fer (PDIC), un syst\u00e8me brevet\u00e9 d'administration de suppl\u00e9ments de fer par voie orale.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/financialpost.com\/globe-newswire\/biosyent-announces-launch-of-new-feramax-pd-maintenance-45\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2024\/02\/inofolic.webp)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Aug 08, 2023<\/div>\n                <div class=\"title\">BioSyent lance Inofolic\u00ae pour les femmes atteintes du syndrome des ovaires polykystiques (SOPK)<\/div>\n                <div class=\"text\">Environ 1,4 million de femmes canadiennes sont atteintes du SOPK, et cette capsule molle unique est approuv\u00e9e pour les aider \u00e0 g\u00e9rer leurs sympt\u00f4mes.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/nationalpost.com\/globe-newswire\/biosyent-launches-inofolic-for-women-with-polycystic-ovary-syndrome-pcos\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/feramax.jpeg)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">September 29, 2021<\/div>\n                <div class=\"title\">BioSyent est sous-\u00e9valu\u00e9e selon cet investisseur<\/div>\n                <div class=\"text\">Si vous \u00eates \u00e0 la recherche d\u2019un nom prometteur dans l\u2019industrie pharmaceutique, renseignez-vous sur l\u2019entreprise canadienne BioSyent. Le gestionnaire de portefeuille Jason Del Vicario de Hillside Wealth Management affirme que son nouveau m\u00e9dicament pourrait \u00eatre tr\u00e8s lucratif.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/www.bnnbloomberg.ca\/video\/jason-del-vicario-discusses-biosyent-inc~2291235\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/Screen-Shot-2022-11-23-at-12.34.37-PM.png)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Apr 27, 2021<\/div>\n                <div class=\"title\">BioSyent : Un joyau des soins de sant\u00e9 sous-\u00e9valu\u00e9 au Canada<\/div>\n                <div class=\"text\">En r\u00e9sum\u00e9, nous croyons qu\u2019aux prix actuels, les march\u00e9s ignorent la croissance g\u00e9n\u00e9r\u00e9e par la direction. \u00c0 notre avis, la solidit\u00e9 des finances de BioSyent, les ant\u00e9c\u00e9dents d\u2019ex\u00e9cution op\u00e9rationnelle et les int\u00e9r\u00eats en jeu de la direction en font une valeur s\u00fbre.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/seekingalpha.com\/article\/4421436-biosyent-undervalued-canadian-healthcare-jewel\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/Screen-Shot-2022-11-22-at-3.47.32-PM.png)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Mar 31, 2021<\/div>\n                <div class=\"title\">Sant\u00e9 Canada a approuv\u00e9 le premier comprim\u00e9 combinant de l\u2019ac\u00e9taminoph\u00e8ne et de l\u2019ibuprof\u00e8ne au pays<\/div>\n                <div class=\"text\">Global News discute avec le Dr Hance Clarke des risques et b\u00e9n\u00e9fices du nouveau m\u00e9dicament approuv\u00e9 pour traiter la douleur aigu\u00eb.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/globalnews.ca\/video\/7730478\/health-canada-has-approved-the-first-acetaminophen-and-ibuprofen-combination-tablet-in-the-country\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/video4.jpg)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Mar 26, 2021<\/div>\n                <div class=\"title\">Dr Hance Clarke, directeur du service de gestion de la douleur au Toronto General Hospital, discute de l\u2019efficacit\u00e9 de CombogesicMD dans une entrevue \u00e0 CTV.<\/div>\n                <div class=\"text\"><\/div>\n                <div class=\"link\"><a href=\"https:\/\/vimeo.com\/manage\/videos\/673297936?embedded=true&amp;source=vimeo_logo&amp;owner=67664403\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/Screen-Shot-2022-11-22-at-3.49.16-PM.png)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Mar 24, 2021<\/div>\n                <div class=\"title\">Nardine Nakhla, professeure \u00e0 l\u2019Universit\u00e9 de Waterloo et pharmacienne communautaire, parle de CombogesicMD.<\/div>\n                <div class=\"text\">Nardine Nakhla, professeure \u00e0 l\u2019Universit\u00e9 de Waterloo et pharmacienne communautaire, parle de CombogesicMD pour soulager la douleur aigu\u00eb dans la revue Pharmacy Practice + Business.<\/div>\n                <div class=\"link\"><a href=\"https:\/\/vimeo.com\/manage\/videos\/678328221?embedded=true&amp;source=vimeo_logo&amp;owner=67664403\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>\n        <div class=\"wpb_coverage\">\n            <div class=\"col1\"><div class=\"image\" style=\"background-image:url(https:\/\/www.biosyent.com\/wp-content\/uploads\/2022\/11\/Screen-Shot-2022-11-22-at-3.50.45-PM.png)\"><\/div><\/div>\n            <div class=\"col2\">\n                <div class=\"date\">Mar 24, 2021<\/div>\n                <div class=\"title\">NewsTalk 1010 \u2013 Entrevue avec le Dr Hance Clarke<\/div>\n                <div class=\"text\"><\/div>\n                <div class=\"link\"><a href=\"https:\/\/vimeo.com\/manage\/videos\/678328321?embedded=true&amp;source=vimeo_logo&amp;owner=67664403\" target=\"_blank\">Continue reading<\/a><\/div>\n            <\/div>\n        <\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb][vc_column][\/vc_column][\/vc_row][vc_row css=\u00a0\u00bb.vc_custom_1668801695899{margin-bottom: 30px !important;}\u00a0\u00bb][vc_column][vc_column_text] Nouvelles [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb][vc_column][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1668801090084{margin-top: 40px !important;margin-bottom: 10px !important;padding-top: 20px !important;padding-bottom: 40px !important;background-color: #f3f9eb !important;}\u00a0\u00bb][vc_column][vc_column_text] Entrevues \u00c9coutez notre PDG nous parler de BioSyent. [\/vc_column_text][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=LW5akxf7U9k\u00a0\u00bb align=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=u-mY4jFzqYA\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=ej_ZbQXdRx0&Prime; css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_video link=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=9AHlGi9e2RM\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=\u00a0\u00bb.vc_custom_1666897497377{margin-top: 40px !important;}\u00a0\u00bb][vc_column][vc_column_text] Couverture Vous pouvez lire les derni\u00e8res nouvelles sur BioSyent, notre &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1965","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pages\/1965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/comments?post=1965"}],"version-history":[{"count":15,"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pages\/1965\/revisions"}],"predecessor-version":[{"id":3121,"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/pages\/1965\/revisions\/3121"}],"wp:attachment":[{"href":"https:\/\/www.biosyent.com\/fr\/wp-json\/wp\/v2\/media?parent=1965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}